N@N

Market Maker Surveillance Report. ULTR, PFE, PRST, CTRP, XRX, BMY, Bullishly Biased Price Friction For Thursday, August 23rd 2

August 23, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 3899 companies with "abnormal" market making, 1961 companies with positive Friction Factors and 3628 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bullish bias) in their stock prices. This means that there was more selling than buying in the stocks and their stock prices rose. Ultrapetrol (Bahamas) Ltd (NASDAQ:ULTR), Pfizer Inc (NYSE:PFE), Presstek Inc (NASDAQ:PRST), Ctrip.Com International Ltd (NASDAQ:CTRP), Xerox Corp (NYSE:XRX), Bristol-Myers Squibb Co (NYSE:BMY). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  ULTR    $0.040    5.41%     34,100       1.67%     2,009,704    98.33%    -1,975,604   Abnormal
  PFE     $0.060    0.25%     5,813,099    27.56%    7,234,581    34.30%    -1,421,482   Abnormal
  PRST    $0.060    13.95%    331,616      22.52%    1,141,056    77.48%    -809,440     Abnormal
  CTRP    $1.360    8.49%     3,560,755    43.29%    4,584,458    55.73%    -1,023,703   Abnormal
  XRX     $0.010    0.14%     1,974,762    23.68%    3,058,773    36.68%    -1,084,011   Abnormal
  BMY     $0.340    1.07%     4,212,005    27.36%    4,965,073    32.26%    -753,068     Abnormal

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above had more selling than buying on Thursday and their stock prices rose. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows ULTR with 1,975,604 greater shares of selling than buying (NetVol) and the stock price was up $0.04000. This means the Market Makers were trading the stock in a way inconsistent with normal supply and demand (Economics 101); more selling than buying should cause prices to drop.

Ultrapetrol (Bahamas) Ltd (NASDAQ:ULTR) - Ultrapetrol (Bahamas) Limited, an industrial shipping company, provides marine transportation services primarily in South America, Europe, and Asia. Its shipping operations encompass grain, forest products, minerals, crude oil, petroleum, and refined petroleum products transportation for the shipping and offshore oil platform supply markets. The company operates in three segments: River, Offshore Supply, and Ocean. The River segment owns and operates river barges and pushboats that transport dry bulk and liquid cargos through the Hidrovia Region of South America. As of December 31, 2009, this segment had 591 barges and 30 pushboats with approximately 1,005,000 deadweight (dwt) capacity. The Offshore Supply segment owns and operates vessels that provide critical logistical and transportation services for offshore petroleum exploration and production companies in the North Sea and the coastal waters of Brazil. This segments fleet consisted of six platform supply vessels (PSVs) in operation and six PSVs under construction. The Ocean segment operated nine ocean-going vessels, including five product tankers, two Capesize vessels, one Oceangoing Pushboat, and one inland tank barge with an aggregate carrying capacity of approximately 445,606 dwt tons. The company was founded in 1992 and is headquartered in Nassau, the Bahamas.

Pfizer Inc (NYSE:PFE) - Pfizer Inc., a biopharmaceutical company, offers prescription medicines for humans and animals worldwide. The company's Biopharmaceutical segments provides Lipitor for elevated LDL-cholesterol levels in the blood; Enbrel for rheumatoid arthritis, polyarticular juvenile rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, and ankylosing spondylitis; Lyrica for post-herpetic neuralgia, diabetic peripheral neuropathy, fibromyalgia, neuropathic pain, adjunctive treatment of epilepsy, and general anxiety disorder, as well as for use as an adjunctive therapy for adult patients with partial onset seizures; Prevnar/Prevenar for invasive pneumococcal disease; Celebrex for osteoarthritis and rheumatoid arthritis, and acute pain; Viagra for erectile dysfunction; Xalabrands for reducing elevated eye pressure; Effexor XR for depressive, generalized anxiety, social anxiety, and panic disorders; and Norvasc for hypertension. It also offers Zyvox for gram-positive pathogens; Premarin for menopausal symptoms; Sutent for renal cell carcinoma; Geodon/Zeldox for schizophrenia; Detrol/Detrol LA for overactive bladder; Zosyn/Tazocin, an intravenous antibiotic; Genotropin for growth hormone deficiency; Vfend, an antifungal agent; and Protonix for gastroesophageal reflux disease; Chantix/Champix for aid smoking cessation; BeneFIX, ReFacto AF, and Xyntha for lifelong bleeding disorder; Caduet for cardiovascular events; Revatio for pulmonary arterial hypertension; Pristiq for depressive disorder; Aricept for Alzheimers disease; and Spiriva for breathing problems. The companys Diversified segment offers animal health products, such as vaccines, anti-infectives, anti-inflammatories, antiemetics, and parasiticides; consumer healthcare products, such as dietary supplements, pain management, respiratory, and personal care; nutrition products; and gelatin, liquid, softgel, non-animal, and fish gelatin capsules. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Presstek Inc (NASDAQ:PRST) - Presstek, Inc., together with its subsidiaries, engages in the design, manufacture, sale, and service of digital imaging solutions to the graphic arts industry worldwide. The companys product line includes Digital Imaging (DI) digital offset presses, computer-to-plate (CPT) systems, workflow solutions, chemistry-free printing plates, no preheat thermal CTP plates, and a line of prepress and press room consumables. Its DI product line includes DI Presses, such as Presstek 52DI Press, Presstek 52DI-AC Press, and Presstek 34DI Press; and DI Plates comprising ProFire Digital Media designed to work as a system with the laser imaging and press components, PearlDry Plus designed to work in conjunction with previous generation DI presses, and PearlDry used for direct-to-press applications. The companys CPT product line consists of compass, Dimension Pro, Dimension Excel, Vector FL52, Presstek DPM Pro 400, and Digital PlateMaster series of platesetters. Its workflow products include Latitude, an automated prepress workflow solution; Momentum RIP designed to drive the companys CTP and DI systems; Momentum Pro Integrated, an integrated workflow and RIP; and PathWay, a Web-to-print business solution. Presstek, Inc. sells its products through direct sales force, independent graphic arts dealers, and strategic OEM partnerships. The company was founded in 1987 and is headquartered in Greenwich, Connecticut.

Ctrip.Com International Ltd (NASDAQ:CTRP) - Ctrip.com International, Ltd., together with its subsidiaries, provides travel services for hotel accommodations, airline tickets, and packaged tours in the Peoples Republic of China. It also sells independent leisure travelers bundled package-tour products, which include transportation and accommodation, as well as guided tours covering various domestic and international destinations. In addition, the company offers Internet-related advertising, aviation casualty insurance, and air-ticket delivery services. Further, it sells Property Management System, a hotel information software; travel guidebooks, which provide information for independent travelers; and VIP membership cards that allow cardholders to receive discounts from various restaurants, clubs, and bars. The company was founded in 1999 and is headquartered in Shanghai, the Peoples Republic of China.

Xerox Corp (NYSE:XRX) - Xerox Corporation engages in the development, manufacture, marketing, service, and finance of document equipment, software, solutions, and services worldwide. The company operates in three segments: Technology, Services, and Other. The Technology segment provides multifunction printers, copiers, digital printing presses, light production devices, and desktop monochrome and color printers for office users. This segment also offers Extensible Interface Platform, a software platform that provides tools to create server based applications; and Xerox Mobile Print Solution, Xerox Mobile Express Driver, and Secure Access Unified ID System. The Services segment offers business process, information technology (IT), and document outsourcing services. Its business process outsourcing services include human resources, customer care, finance and accounting, healthcare payer and insurance, government services and solutions, transportation solutions, and card fare payment solutions. This segments IT outsourcing services comprise data center outsourcing, server outsourcing, network outsourcing, remote infrastructure management, help desk/service desk management, desktop outsourcing, managed storage, utility computing, disaster recovery, security, and IT commercial services. Its document outsourcing services include managed print services; consolidating in-house production and commercial printing; communication processes and back-office functions; designing, authoring, and translating technical documentation; and creating personalized and multi-channel marketing communications. The Other segment primarily sells paper, wide-format systems, and GIS network integration solutions and electronic presentation systems. The company sells its products and solutions through its sales force, as well as through a network of independent agents, dealers, value-added resellers, systems integrators, and the Web. Xerox Corporation was founded in 1906 and is headquartered in Norwalk, Connecticut.

Bristol-Myers Squibb Co (NYSE:BMY) - Bristol-Myers Squibb Company, a global biopharmaceutical company, discovers, develops, and delivers innovative medicines that help patients prevail over serious diseases. The company focuses on areas of serious unmet medical needs, such as cardiovascular disease, mental illness, cancer, HIV/AIDS, hepatitis B and C, rheumatoid arthritis, type 2 diabetes, solid organ transplantation, and Alzheimer's disease. Its principal products include PLAVIX for protection against fatal or non-fatal heart attack or stroke; AVAPRO/AVALIDE for the treatment of hypertension and diabetic nephropathy; ABILIFY, an agent for adult patients with schizophrenia, bipolar mania disorder, and depressive disorder; and REYATAZ for the treatment of HIV. The companys principal products also comprise SUSTIVA for the treatment of HIV; BARACLUDE, an inhibitor of hepatitis B virus; ERBITUX to target and block the epidermal growth factor receptor; SPRYCEL for treatment of chronic myeloid leukemia in adults; IXEMPRA to treat breast cancer; ORENCIA to severe rheumatoid arthritis in adults; and ONGLYZA for the treatment of type 2 diabetes. Its products under Phase III clinical trials include ELIQUIS to prevent and treat venous thromboembolic disorders and stroke prevention in atrial fibrillation; NULOJIX to prevent solid organ transplant rejection; Brivanib to block the VEGF and the FGF receptors; Dapagliflozin to treat diabetes; YERVOY to treat metastatic melanoma; and Necitumumab for anticancer treatment. The company sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, and pharmacies. It has strategic alliances with sanofi-aventis; Pfizer, Inc.; AstraZeneca PLC; Otsuka Pharmaceutical Co., Ltd.; Eli Lilly and Company; and Gilead Sciences, Inc. The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net